Clinical Trial Update: Spinal Cord Injury - Assessing Tolerability and Use of Combined Rehabilitation and NeuroAiD [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating tolerability and the use of combined rehabilitation with NeuroAiD for spinal cord injury has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• NeuroAid

Snippet

Sponsor: Moleac Pte Ltd. | Conditions: Spinal Cord Injury | Phase 4 | Status: COMPLETED